Advanced search
Publication Cover
Gynecological Endocrinology Volume 37, 2021 - Issue 1
Submit an article Journal homepage
165
Views
3
CrossRef citations to date
0
Altmetric
HYPERANDROGENISM

The abnormal expression of kisspeptin regulates pro-inflammatory cytokines, cell viability and apoptosis of macrophages in hyperandrogenism induced by testosterone

Xiao Lia Gynecology Department, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China;b The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, ChinaView further author information
,
Lingchuan Lia Gynecology Department, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China;b The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, ChinaView further author information
,
Dimei Ouyanga Gynecology Department, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China;b The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, ChinaView further author information
,
Yuyao Zhua Gynecology Department, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China;b The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, ChinaView further author information
&
Tao Yuana Gynecology Department, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China;b The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, ChinaCorrespondence[email protected]
View further author information
Pages 72-77 | Received 20 Apr 2020, Accepted 15 Aug 2020, Published online: 29 Sep 2020

References

  • Hirschberg AL. Hyperandrogenism in female athletes. J Clin Endocrinol Metab. 2019;104(2):503–505.
  • Abbott DH, Barnett DK, Bruns CM, et al. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update. 2005;11(4):357–374.
  • Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520.
  • Pfieffer ML. Polycystic ovary syndrome: an update. Nursing. 2019;49(8):34–40.
  • Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
  • Ramezani Tehrani F, Amiri M. Polycystic ovary syndrome in adolescents: challenges in diagnosis and treatment. Int J Endocrinol Metab. 2019;17(3):e91554.
  • Lizneva D, Kirubakaran R, Mykhalchenko K, et al. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertil Steril. 2016;106(6):1510–1520.e2.
  • Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, et al. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol. 2019;53(4):955–966.
  • Cesta CE, Oberg AS, Ibrahimson A, et al. Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding? Psychol Med. 2020;50(4):616–624.
  • Sam S, Ehrmann DA. Hormonal evaluation of hyperandrogenism in women. JAMA. 2015;314(23):2557–2558.
  • Greenhill C. Genetic analysis reveals role of testosterone levels in human disease. Nat Rev Endocrinol. 2020;16(4):195.
  • Filippou P, Homburg R. Is foetal hyperexposure to androgens a cause of PCOS? Hum Reprod Update. 2017;23(4):421–432.
  • Tena-Sempere M. Timeline: the role of kisspeptins in reproductive biology. Nat Med. 2008;14(11):1196.
  • Topaloglu AK, Tello JA, Kotan LD, et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med. 2012;366(7):629–635.
  • Iwasa T, Matsuzaki T, Murakami M, et al. Decreased expression of kisspeptin mediates acute immune/inflammatory stress-induced suppression of gonadotropin secretion in female rat. J Endocrinol Invest. 2008;31(7):656–659.
  • Cardoso NS, Ribeiro VB, Dutra SGV, et al. Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin. Arch Endocrinol Metab. 2020;64(1):4–10.
  • Rudnicka E, Kunicki M, Suchta K, et al. Inflammatory Markers in Women with Polycystic Ovary Syndrome. Biomed Res Int. 2020;2020:4092470.
  • Pate JL, Toyokawa K, Walusimbi S, et al. The interface of the immune and reproductive systems in the ovary: lessons learned from the corpus luteum of domestic animal models. Am J Reprod Immunol. 2010;64(4):275–286.
  • Oakley OR, Frazer ML, Ko C. Pituitary-ovary-spleen axis in ovulation. Trends Endocrinol Metab. 2011;22(9):345–352.
  • Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med. 2007;43(5):645–657.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
  • Birkhead II, Schwabl II, Burke II. Testosterone and maternal effects - integrating mechanisms and function. Trends Ecol. Evol. (Amst.). 2000;15(3):86–87.
  • Legro RS, Arslanian SA, Ehrmann DA, Endocrine Society, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–4592.
  • Topaloglu AK, Tello JA, Kotan LD, et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med. 2012;366(7):629–635.
  • d'Anglemont de Tassigny X, Fagg LA, Dixon JP, et al. Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc Natl Acad Sci USA. 2007;104(25):10714–10719.
  • Mayer C, Boehm U. Female reproductive maturation in the absence of kisspeptin/GPR54 signaling. Nat Neurosci. 2011;14(6):704–710.
  • Sagoo P, Chan G, Larkin DF, et al. Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci. 2004;45(11):3964–3973.
  • Wu B, Fujise T, Iwakiri R, et al. Venous congestion induces mucosal apoptosis via tumor necrosis factor-alpha-mediated cell death in the rat small intestine. J Gastroenterol. 2004;39(11):1056–1062.
  • Sato K, Shirai R, Hontani M, et al. Potent vasoconstrictor kisspeptin-10 induces atherosclerotic plaque progression and instability: reversal by its receptor GPR54 antagonist. J Am Heart Assoc. 2017;6(4):e005790.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.